Cargando…
The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy
RATIONALE: Risperidone is the first antipsychotic to be approved by Food and Drug Administration (FDA) for treating autism spectrum disorder (ASD). The potential efficacy of metformin in preventing and/or controlling ASD behavioral deficits was also recently reported. Suppression of hippocampus auto...
Autores principales: | Atia, Amany AA, Ashour, Rehab H, Zaki, Marwa MAF, Rahman, Karawan MA, Ramadan, Nehal M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172247/ https://www.ncbi.nlm.nih.gov/pubmed/37133558 http://dx.doi.org/10.1007/s00213-023-06371-1 |
Ejemplares similares
-
Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder
por: Román, Viktor, et al.
Publicado: (2021) -
Alterations of the Hippocampal Networks in Valproic Acid-Induced Rat Autism Model
por: Bódi, Veronika, et al.
Publicado: (2022) -
The valproic acid rat model of autism presents with gut bacterial dysbiosis similar to that in human autism
por: Liu, Fang, et al.
Publicado: (2018) -
Modulatory Role of Autophagy in Metformin Therapeutic Activity toward Doxorubicin-Induced Nephrotoxicity
por: Antar, Samar A., et al.
Publicado: (2023) -
Late onset deficits in synaptic plasticity in the valproic acid rat model of autism
por: Martin, Henry G. S., et al.
Publicado: (2014)